Theravance Biopharma, Inc. (TBPH) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $2.06 | +279.1% |
| 2024 | $-1.15 | -15.0% |
| 2023 | $-1.00 | -108.4% |
| 2022 | $11.85 | +512.9% |
| 2021 | $-2.87 | +35.7% |
| 2020 | $-4.46 | -4.9% |
| 2019 | $-4.25 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $2.06 | +279.1% |
| 2024 | $-1.15 | -15.0% |
| 2023 | $-1.00 | -108.4% |
| 2022 | $11.85 | +512.9% |
| 2021 | $-2.87 | +35.7% |
| 2020 | $-4.46 | -4.9% |
| 2019 | $-4.25 | — |